PMID- 36431350
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221213
IS  - 2077-0383 (Print)
IS  - 2077-0383 (Electronic)
IS  - 2077-0383 (Linking)
VI  - 11
IP  - 22
DP  - 2022 Nov 21
TI  - Long-Term Outcomes following Common Femoral Endarterectomy.
LID - 10.3390/jcm11226873 [doi]
LID - 6873
AB  - Thromboendarterectomy of the common femoral artery (CFA) for occlusive disease is 
      a crucial procedure in vascular surgery. As an outcome reference for emerging 
      endovascular procedures and new devices, we need more robust evidence of the 
      outcome of this gold standard technique. The purpose of this study was to report 
      10-year results after femoral endarterectomy (FEA). A retrospective review of 
      medical records at our institution identified eighty consecutive patients (91 
      limbs) who underwent FEA for CFA lesions. Indications for FEA included 50 limbs 
      (55%) for intermittent claudication (IC) and 39 limbs (43%) with chronic 
      limb-threatening ischemia (CLTI). Two limbs (2%) underwent FEA to prevent 
      hemodynamic steal during extra-anatomical bypass. Adjunctive procedures included 
      endovascular therapy in 32%. CFAs were closed with patch angioplasty in 44%. With 
      a mean follow-up period of 39 months, the survival rates at 3 and 8 years were 
      85% and 77%, respectively. Limb salvage rates were 92% and 87%. Primary patencies 
      were 98% and 84%. Freedom from target lesion revascularization was 95% at 3 years 
      and 91% at 8 years. Our findings support the durability of FEA, with comparable 
      long-term procedural results in CLTI patients as well as IC patients. Since the 
      FEA is a gate maneuver for hybrid revascularization in CLTI patients, our 
      findings support a strategy combining open and endovascular approaches. Femoral 
      endarterectomy remains a durable solution for common femoral occlusive disease in 
      IC and CLTI in the era of endovascular therapy.
FAU - Hashimoto, Takuya
AU  - Hashimoto T
AUID- ORCID: 0000-0002-7690-1046
AD  - Department of Vascular Surgery, Saitama Medical Center, Saitama Medical 
      University, Kawagoe 350-0844, Japan.
FAU - Yamamoto, Satoshi
AU  - Yamamoto S
AD  - Department of Surgery, Ome Municipal General Hospital, Ome 198-0042, Japan.
FAU - Kimura, Masaru
AU  - Kimura M
AD  - Department of Vascular Surgery, Saitama Medical Center, Saitama Medical 
      University, Kawagoe 350-0844, Japan.
FAU - Sano, Masaya
AU  - Sano M
AD  - Department of Vascular Surgery, Saitama Medical Center, Saitama Medical 
      University, Kawagoe 350-0844, Japan.
FAU - Sato, Osamu
AU  - Sato O
AD  - Department of Vascular Surgery, Saitama Medical Center, Saitama Medical 
      University, Kawagoe 350-0844, Japan.
FAU - Deguchi, Juno
AU  - Deguchi J
AD  - Department of Vascular Surgery, Saitama Medical Center, Saitama Medical 
      University, Kawagoe 350-0844, Japan.
LA  - eng
PT  - Journal Article
DEP - 20221121
PL  - Switzerland
TA  - J Clin Med
JT  - Journal of clinical medicine
JID - 101606588
PMC - PMC9697575
OTO - NOTNLM
OT  - common femoral endarterectomy
OT  - peripheral artery disease
OT  - revascularization
COIS- The authors declare no conflict of interest.
EDAT- 2022/11/27 06:00
MHDA- 2022/11/27 06:01
PMCR- 2022/11/21
CRDT- 2022/11/26 01:23
PHST- 2022/10/03 00:00 [received]
PHST- 2022/11/08 00:00 [revised]
PHST- 2022/11/18 00:00 [accepted]
PHST- 2022/11/26 01:23 [entrez]
PHST- 2022/11/27 06:00 [pubmed]
PHST- 2022/11/27 06:01 [medline]
PHST- 2022/11/21 00:00 [pmc-release]
AID - jcm11226873 [pii]
AID - jcm-11-06873 [pii]
AID - 10.3390/jcm11226873 [doi]
PST - epublish
SO  - J Clin Med. 2022 Nov 21;11(22):6873. doi: 10.3390/jcm11226873.